Stocks › CTY
CITY THERAPEUTICS, INC.
CTY·Nasdaq·
United States·USD
$19.32
+0.97 (+5.29%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
CTY
CITY THERAPEUTICS, INC. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CTYS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of CTY by members of U.S. Congress · 1 on record
| Politician | Stock | Type | Filed | Traded | |
|---|---|---|---|---|---|
Raúl M. GrijalvaHouse · D · AZ |
CTYCITY THERAPEUTICS, INC. · Stock |
Sale $1,001 - $15,000 |
Feb 5, 2014 | Jan 15, 2014 | Filing ↗ |
Whale Activity
Position changes in CTY reported for 2020-12-31 by 1 institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed1
- No prior filing0
| Filer | Shares | Value | Change |
|---|---|---|---|
| CARY STREET PARTNER INVESTMENT ADVISORY LLC | 0 | $0 | closed |
Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.
Insider Trading
Net shares bought (+) or sold (−) on the open market by CTY insiders, by quarter · Form 4
Recent Insider Transactions
2 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| ARCH Venture Partners XII, LLC / ARCH Venture Partners XII, L.P. / ARCH Venture Fund XII, L.P. / CRANDELL KEITH / Burow Kristina / GILLIS STEVEN | Purchase | +170.0K | n/c | — | Oct 19, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding CTY · SEC Form N-PORT
No mutual fund or ETF has reported CTY in an N-PORT filing in the last seven months.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
- Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 7.0M shares14.0%
Nov 6, 2026 · ↗ - FMR LLCSCHEDULE 13G · passive (13G) · 7.0M shares14.0%
Nov 6, 2026 · ↗ - Steven GillisSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - Kristina BurowSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - Keith CrandellSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - Robert NelsenSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - ARCH Venture Partners XII, LLCSCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - ARCH Venture Partners XII, L.P.SCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - ARCH Venture Fund XII, L.P.SCHEDULE 13D · activist (13D) · 13.7M shares25.6%
Oct 26, 2026 · ↗ - HALVORSEN OLE ANDREASSCHEDULE 13G · passive (13G) · 3.7M shares7.0%
Oct 26, 2026 · ↗
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming CITY THERAPEUTICS, INC. as client
No lobbying filings found naming CITY THERAPEUTICS, INC. as the client.
Government Contracts
Federal awards to CITY THERAPEUTICS, INC. · USAspending
No federal contract awards found for CITY THERAPEUTICS, INC..
U.S. Patents
Recent USPTO applications naming CITY THERAPEUTICS, INC.
No USPTO patent applications found for CITY THERAPEUTICS, INC..
Annual Financials
From CTY's 10-K filings · XBRL
SEC holds no annual XBRL figures in US dollars for CITY THERAPEUTICS, INC..
Stock Splits
Every split and reverse split in the price history
No stock splits in CTY's price history.
About CITY THERAPEUTICS, INC.
From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersCAMBRIDGE, MA
IncorporatedDE
SEC CIK0002143850 ↗

